Phospho-β-Catenin (Ser33) Antibody (Rabbit mAb) [M22A24]

CatNo: F5139

    Application: Reactivity:
    • Lane 1: HT-29, Lane 2: HT-29 (Calyculin A, 100nM, 30 min)
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    120秒以上の露光(暴露)を推奨します。

    使用情報

    Dilution
    1:5000-1:50000
    1:500-1:2000
    1:4000
    Application
    WB, IF, FCM, ELISA
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Human, Rat
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    85 kDa 90 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール PC-3 cells (treated with Calyculin A)
    ネガティブコントロール PC-3 cells

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use primary antibody dilution buffer to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:5000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system. (Exposure time of at least 120s is recommended)
    IF
    Experimental Protocol:
     
    Sample Preparation
    1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use.
    2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine.
    3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time.
    4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval.
     
    Fixation
    1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes.
    2. Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Permeabilization
    1.Add a detergent such as 0.1–0.3% Triton X-100 to the sample and incubate at room temperature for 10–20 minutes.
    (Note: This step is only required for intracellular antigens. For antigens expressed on the cell membrane, this step is unnecessary.)
    Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Blocking
    Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.)
    Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background.
     
    Immunofluorescence Staining (Day 1)
    1. Remove the blocking solution and add the diluted primary antibody.
    2. Incubate the sample in a humidified chamber at 4°C overnight.
     
    Immunofluorescence Staining (Day 2)
    1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time.
    2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours.
    3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time.
    4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes.
    5. Wash with PBST for 3 times, 5 minutes each time.
     
    Mounting
    1. Mount the sample with an anti-fade mounting medium.
    2. Allow the slide to dry at room temperature overnight in the dark.
    3. Store the slide in a slide storage box at 4°C, protected from light.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    Phospho-β-Catenin (Ser33) Antibody (Rabbit mAb) [M22A24] detects endogenous levels of total β-Catenin protein only when it is phosphorylated at Ser33.
    タンパク質の局在
    細胞接着、細胞膜、細胞突起、細胞質、細胞骨格、細胞内膜系、細胞核、シナプス
    Uniprot ID
    P35222
    Clone
    M22A24
    Synonym(s)
    Catenin beta-1, Beta-catenin, CTNNB1, CTNNB
    Background
    β-catenin functions as the central effector of the canonical Wnt signaling pathway, operating both as a structural component of adherens junctions through its interaction with α-catenin and E-cadherin and as a transcriptional coactivator once released into the cytoplasm and nucleus, with phosphorylation at Ser33 marking the protein for degradation and thereby controlling which of these two roles it can perform. In the absence of Wnt ligand, cytosolic β-catenin is captured by the destruction complex, a multiprotein assembly built around Axin as the central scaffold, which directly binds APC, casein kinase 1 alpha, GSK3, and β-catenin itself, with Axin acting as the rate-limiting factor whose self-polymerization is required for efficient β-catenin recruitment into the complex. Before phosphorylation can proceed, α-catenin must first dissociate from β-catenin, an event triggered by tyrosine phosphorylation at Tyr142 mediated by the Src-family kinases FER and FYN, which grants casein kinase 1 alpha access to its substrate. Casein kinase 1 alpha then phosphorylates β-catenin at Ser45, and this modification creates a priming site that is necessary and sufficient for GSK3 to carry out sequential phosphorylation of the more N-terminal residues Thr41, then Ser37, and finally Ser33, generating a cluster of phosphorylated residues collectively referred to as the phosphodegron. Crystal structures of APC bound to phosphorylated versus nonphosphorylated β-catenin reveal that CK1 and GSK3 substrate sequences within APC itself undergo mutual priming phosphorylation, generating a phosphorylation-dependent binding motif that increases APC's affinity for β-catenin and stabilizes the destruction complex during the phosphorylation cycle. Once Ser33 and Ser37 are phosphorylated, these two residues together create the recognition site engaged by the F-box protein β-TrCP, the substrate-recognition subunit of the SCF ubiquitin ligase complex, and β-TrCP binding triggers polyubiquitination of β-catenin, targeting it for proteasomal degradation and keeping cytosolic β-catenin levels low under resting conditions. Reconstitution of the full human destruction complex confirms that a subpopulation of complex-bound β-catenin carries authentic phosphorylation at both the CK1-targeted Ser45 site and the GSK3-targeted Ser33, Ser37, and Thr41 sites, validating the sequential priming mechanism in a purified biochemical system. Mutations at Ser33, Ser37, or Thr41 prevent this phosphorylation-dependent degradation cycle, stabilizing β-catenin protein independent of upstream Wnt signal, and such mutations are recurrently found in tumor cell lines, making loss of Ser33 phosphorylation a defined molecular readout of destruction complex failure and aberrant Wnt pathway activation in cancer.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください